Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?

The scientific community has risen to the coronavirus disease 2019 (COVID‐19) challenge, coming up with an impressive list of candidate drugs and vaccines targeting an array of pharmacological and immunological mechanisms. Yet, generating clinical evidence of efficacy and safety of these candidate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, Hans‐Georg, Cavaleri, Marco, Enzmann, Harald, Scotti, Francesca, Sepodes, Bruno, Sweeney, Fergus, Vamvakas, Spiros, Rasi, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272975/
https://www.ncbi.nlm.nih.gov/pubmed/32407539
http://dx.doi.org/10.1002/cpt.1891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272975/
https://www.ncbi.nlm.nih.gov/pubmed/32407539
http://dx.doi.org/10.1002/cpt.1891

Ejemplares similares